The EIOC Journal Club was organized on 18 September 2023, where a panel of 6 speakers discusses on current paper revolving around Optimal Integration of the Approved Oral SERDs in Routine Clinical Practice

The EIOC Journal Club was organized on 07 September 2023, where a panel of 6 speakers discusses on current paper revolving around Practical Consideration and Therapy Management of CDK4/6i in MBC Setting

The EIOC Journal Club was organized on 14 August 2023, where a panel of 6 speakers discusses on current paper revolving around Treatment Selection & Sequencing in High-Risk gBRCAm HR+, HER2- eBC and gBRCAm eTNBC

The EIOC Journal Club was organized on 23 June 2023, where a panel of 7 speakers discusses on current paper revolving around From Bench to Bedside: The Future for High Risk Patients in Early Breast Cancer.

The EIOC Journal Club was organized on 22 June 2023, where a panel of 10 speakers discusses on current paper revolving around Latest Updates of CDK4/6 Inhibitors in the Management of HR+ HER2- eBC.

The EIOC Journal Club was organized on 12 June 2023, where a panel of 4 speakers discusses on current paper revolving around Highlights & Updates from ASCO: Key Abstracts & Presentations.

The EIOC Journal Club was organized on 29 May 2023, where a panel of 6 speakers discusses on current paper revolving around IO in Upper GI Cancer Management.

The EIOC Journal Club was organized on 17 May 2023, where a panel of 4 speakers discusses on current paper revolving around Is Liquid Now Solid? Recent Updates on the Clinical Applications of Liquid Biopsies for Precision Oncology in Advanced NSCLC.

The EIOC Journal Club was organized on 08 May 2023, where a panel of 4 speakers discusses on current paper revolving around Updated in the Management of mHSPC.

The EIOC Journal Club was organized on 17 April 2023, where a panel of 8 speakers discusses on current paper revolving around Optimal Sequencing of Therapy in HER2 Low mBC.

The EIOC Journal Club was organized on 20 March 2023, where a panel of 4 speakers discusses on current paper revolving around High-Risk Breast Cancer Highlights in Early and Advanced Setting

The EIOC Journal Club was organized on 06 March 2023, where a panel of 6 speakers discusses on current paper revolving around High Risk Pre-Menopausal Hormonal +ve Early-Stage Breast Cancer

The EIOC Journal Club was organized on 28 February 2023, where a panel of 4 speakers discusses on current paper revolving around Management of HER2+ Metastatic Breast Cancer Patients  

The EIOC Journal Club was organized on 22 February 2023, where a panel of 5 speakers discusses on current paper revolving around Management of HR+ HER2- mBC Patients

The EIOC Journal Club was organized on 13 February 2023, where a panel of 4 speakers discusses on current paper revolving around Current Treatment Paradigm for HER2+ Early BC & mBC 

The EIOC Journal Club was organized on 19 December 2022, where a panel of 6 speakers discusses on current paper revolving around Integration of the Latest Evidence into the Management of Metastatic Triple Negative Breast Cancer.

The EIOC Journal Club was organized on 14 October 2022, where a panel of 11 speakers discusses on current paper revolving around Management of HER2 Low Breast Cancer

The EIOC Journal Club was organized on 08 July 2022, where a panel of 6 speakers discusses on current paper revolving around Highlights & Updates from ASCO: Key Abstracts & Presentations

The EIOC Journal Club was organized on 02 July 2022, where a panel of 6 speakers discusses on current paper revolving around Shifting Perspectives in HR+/HER2- Advanced Breast Cancer

The EIOC Journal Club was organized on 10 June  2022, where a panel of 6 speakers discusses on current paper revolving around Role of Immunotherapy in NSCLC

The EIOC Journal Club was organized on 27 May 2022, where a panel of 7 speakers discusses on current paper revolving around Making Precision Oncology the Standard of Care

The EIOC Journal Club was organized on 20 May 2022, where a panel of 6 speakers discusses on current paper revolving around Increasing Access to Breast Cancer Treatment through Biosimilars 

The EIOC Journal Club was organized on 22 April 2022, where a panel of 5 speakers discusses on current paper revolving around High Risk Pre-Menopausal Hormonal +ve Early Stage Breast Cancer

The EIOC Journal Club was organized on 25 February 2022, where a panel of 9 speakers discusses on current paper revolving around Clinical Utility of ctDNA for CRC and Immunotherapy response monitoring

The sixth EIOC Journal Club was organized on 4 December 2021, where a panel of 11 speakers discusses on current paper revolving around Optimising Therapy in Hormone Receptor Positive Breast Cancer

The fifth EIOC Journal Club was organized on 28 August 2021, where a panel of 11 speakers discusses on current paper revolving around Deconstructing OlympiA and IO in early-stage TNBC : Is it time to change practice?

The fouth EIOC Journal Club was organized on 16 July 2021, where a panel of 8 speakers discusses on current paper revolving around Immunotherapy and Targeted Approaches for Gynae Malignancies

The third EIOC Journal Club was organized on 2 July 2021, where a panel of 10 speakers discusses on current paper revolving around “Hormone receptive positive Breast Cancer”

The second EIOC Journal Club was organized on 25 June 2021, where a panel of 10 speakers discusses on current paper revolving around Triple- Negative and HER2 positive Breast Cancer

The first EIOC Journal Club was organized on 21 May 2021, where a panel of 10 speakers discusses on current paper revolving around Genomic Testing, Ovarian Function Suppression, Hormone receptor positive HER2 – eBC.